GHRP-6 research has revealed a dual pharmacological profile, with GHSR-1a activation in hypothalamic AgRP/NPY neurons mediating orexigenic circuit modulation distinct from the pituitary somatotroph GH-secretion pathway.
A review of CJC-1295 DAC research examining the maleimidopropionic acid albumin-binding mechanism, half-life extension pharmacokinetics, and pulsatile GH secretion patterns in preclinical and Phase I data.
An analysis of Tesamorelin’s GHRHR class B GPCR binding mechanism, DPP-IV resistance from its trans-3-hexenoyl modification, and the inferred downstream lipolysis cascade in visceral adipose tissue research.
This article reviews preclinical evidence on ipamorelin’s GHS-R1a-mediated calcium signaling cascade in pituitary somatotrophs, examining the IP3/L-VGCC pathway, PKC downstream activation, and the structural basis for its selectivity over other growth hormone secretagogues.
A mechanistic review of GHRP-6’s GHS-R1a receptor coupling, downstream GH-IGF-1 axis activation, and the inferred PI3K-Akt-mTOR anabolic signaling pathway in skeletal muscle preclinical models.
A research-context examination of Ipamorelin’s selectivity profile at GHS-R1a, including biased agonism toward Gaq pathways, receptor heterodimerization dynamics, and constitutive activity in somatotroph models.
A mechanistic review of CJC-1295’s Drug Affinity Complex modification, its albumin-binding half-life extension, and the implications of sustained GHRH receptor occupancy for pulsatile GH secretion patterns in somatotroph biology.
Sermorelin is a synthetic GHRH(1-29) analog studied for its two-step GHRHR class B GPCR binding mechanism and Gs-cAMP-PKA-CREB-Pit-1 cascade activation in pituitary somatotrophs.
A research-context examination of MK-677’s non-peptide GHSR-1a agonism, including Gq/11-PLC-PKC-IP3 calcium signaling, tonic GH secretion pattern characteristics, and mechanistic distinctions from peptide-based GH secretagogues in preclinical research.
A preclinical research overview of GHRP-2 focusing on Hepatic GH receptor (GHR) downstream signaling following GHRP-2-induced GH release: JAK2-STAT5b phos…